ArticleNAR genomics and bioinformatics2026
Comparative evaluation of the prediction accuracy of AlphaFold and ESMFold for monomeric and dimeric proteins.
Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antibody-drug conjugate engineering: from design to efficacy and safety.Signal transduction and targeted therapy · 2026Review
- From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Adversarial Sequence Mutations in AlphaFold and ESMFold Reveal Nonphysical Structural Invariance, Confidence Failures, and Concerns for Protein Design.Computational and structural biotechnology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have evaluated the prediction accuracy of three different tools, deep-learning-based AlphaFold2, AlphaFold3, and large language model-based ESMFold, utilizing the experimentally derived structures deposited in the Protein Data Bank between 2022 and 2024, excluding those entries with close homologs in the structures released prior to 2022. Based on the criteria of sequence identity lower than 40% and query coverage <70%, 1666 monomeric and 994 dimeric proteins were selected as challenging targets for benchmarking. Our analysis showed that AlphaFold2 and AlphaFold3 correctly predicted 88% of monomeric structures and 77% of dimeric proteins. On the other hand, ESMFold accurately predicted 76% of the monomeric proteins and 41% of the dimeric proteins. Since most incorrect predictions involved nuclear magnetic resonance structures, benchmarking on X-ray and cryo-electron microscopy structures showed that the prediction accuracy of AlphaFold and ESMFold was 95% and 83%, respectively, for monomeric proteins. Overall, these findings demonstrate significant differences in the prediction accuracy of these machine learning (ML)-based tools for monomeric and dimeric proteins, highlighting the advantages and limitations of these tools. Finally, to facilitate easy access to benchmarking data, we developed ProModEv (Protein Model Evaluation portal), an interactive web portal for systematic analysis of these benchmarking results, and it is available at http://pdbi.nii.ac.in/ProModEv/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.